Clinical Trials Logo

Clinical Trial Summary

Somatic mosaicism in cancer associated genes is one potential explanation for discordance in childhood cancer that has not been fully explored to date. This pilot study will focus on twins with central nervous system (CNS) tumors who are identified through the Children's Oncology Group's Project: EveryChild (PEC) registry or volunteer.


Clinical Trial Description

PRIMARY OBJECTIVES: I. To conduct a descriptive study of same sex twins (MZ and DZ) discordant for childhood CNS tumors identified through the Children's Oncology Group Project:EveryChild registry. II. To compare the prevalence of somatic mosaicism in classic cancer-associated genes in monozygotic (MZ) twins discordant for childhood brain tumors. In our pilot study, we will sequence blood and saliva DNA samples from 25 MZ twin pairs using a panel of 94 known cancer associated genes. SECONDARY OBJECTIVES: I. To compare the profile of mutations detected in DNA extracted from pre- and post-treatment blood samples from a subset of CNS tumor patients. The purpose of this aim is to ensure that differences in somatic mosaicism detected in twin pairs are not caused by cancer therapy. Outline: Twins with CNS tumors will undergo blood and saliva DNA samples with the goal is to learn more about genetic differences that may lead to CNS tumor development. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06054295
Study type Observational
Source Children's Oncology Group
Contact Jenny Poynter, PhD
Phone (612) 625-4232
Email poynt006@umn.edu
Status Recruiting
Phase
Start date June 3, 2024
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04743310 - Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System Phase 2
Completed NCT02496520 - Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults Phase 1/Phase 2
Completed NCT00002594 - Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors Phase 2
Active, not recruiting NCT02932280 - Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment Phase 1/Phase 2
Completed NCT00078988 - High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Phase 3
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT00238264 - Radiation Therapy in Treating Young Patients With Gliomas Phase 2
Completed NCT00006024 - Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Completed NCT03981016 - Medical and Surgical Management of Patients With Brain Metastases N/A
Completed NCT00716976 - Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Phase 3
Recruiting NCT05978557 - Brain Slice Explants to Predict Drug Response in Brain Tumors
Recruiting NCT04852354 - Tissue Collection for Drug Screening and Bioanalysis
Completed NCT00077207 - Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma N/A
Completed NCT00085098 - Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor Phase 3
Active, not recruiting NCT03052738 - Medical Marijuana in the Pediatric Central Nervous System Tumor Population
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Terminated NCT04096716 - Mapping Draining Lymph Nodes in CNS Malignancies Phase 1
Recruiting NCT01595126 - Longitudinal Study of Biomarkers N/A
Recruiting NCT04185038 - Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors Phase 1